EICHOR
● Active Not Recruiting
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Condition: Advanced Malignant Solid Neoplasm · Anorexia · Hematopoietic and Lymphoid Cell Neoplasm · Sponsor: Alliance for Clinical Trials in Oncology
About this study
This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine may stimulate and increase appetite. This study aims to find out if olanzapine is better than the usual approach (megestrol acetate) for stimulating appetite and preventing weight loss.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (293)
| Arizona Center for Cancer Care - Gilbert | Gilbert, Arizona, United States | — |
| CTCA at Western Regional Medical Center | Goodyear, Arizona, United States | — |
| Arizona Center for Cancer Care-Peoria | Peoria, Arizona, United States | — |
| Arizona Center for Cancer Care - Phoenix | Phoenix, Arizona, United States | — |
| Arizona Center for Cancer Care - Osborn | Scottsdale, Arizona, United States | — |
| Arizona Center for Cancer Care - Scottsdale | Scottsdale, Arizona, United States | — |
| Arizona Center for Cancer Care-Surprise | Surprise, Arizona, United States | — |
| NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro | Jonesboro, Arkansas, United States | — |
| Epic Care-Dublin | Dublin, California, United States | — |
| Epic Care Partners in Cancer Care | Emeryville, California, United States | — |
| Washington Hospital | Fremont, California, United States | — |
| Contra Costa Regional Medical Center | Martinez, California, United States | — |
+ 281 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04939090